6 Results for "

chondrosarcoma

" in MedChemExpress (MCE) Product Catalog:
Products (6)

6 Results for "chondrosarcoma" in MCE Product Catalog:

2
2 Cited Publications
Cat. No.: HY-145594
CAS No.: 1898206-17-1
Synonyms: AB-291; DS-1001
Research Areas:  

Cancer

Safusidenib (AB-291; DS-1001) is an orally bioavailable, selective mutant IDH1 inhibitor. Safusidenib strongly inhibits mutant IDH1 but not wild-type IDH1. Safusidenib impairs tumor activity in chondrosarcoma . Safusidenib exhibits activity against IDH1R132H, and IDH1R132C with IC50s of 15, and 130 nM in assays without any preincubation, respectively .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-147025
CAS No.: 2347517-69-3
Purity:  99.06%
(S,R,S)-AHPC-C2-amide-benzofuranylmethyl-pyridine is a dual-targeting PROTAC molecule. (S,R,S)-AHPC-C2-amide-benzofuranylmethyl-pyridine not only targets the ubiquitination and degradation of Smad3, but also elevates the protein level of HIF-α, thereby exerting multi-pathway anti-fibrotic and renoprotective effects. (S,R,S)-AHPC-C2-amide-benzofuranylmethyl-pyridine can be used in a wide range of tumor studies including cancers with KRAS inhibitor resistance, covering pancreatic ductal adenocarcinoma, acute myeloid leukemia, and various soft tissue sarcomas (such as fibrosarcoma, liposarcoma, chondrosarcoma, etc.). (S,R,S)-AHPC-C2-amide-benzofuranylmethyl-pyridine can also be applied to research related to various solid tumors and hematological malignancies, involving multiple cancer types such as colon cancer, breast cancer, ovarian cancer, non-small cell lung cancer, glioblastoma, and melanoma .
loading...
    loading...
Cat. No.: HY-P990715
CAS No.: 2539847-03-3
Synonyms: INBRX-109

Target:  

TNF Receptor

Research Areas:  

Cancer

Ozekibart (INBRX-109) is a DR5 agonist and antitumor agent with a human DR5 IC50 of 0.17 nmol/L and human DR5 Ka of 0.11 nmol/L. Ozekibart can be used for the research of unresectable/metastatic chondrosarcoma .
loading...
    loading...
Cat. No.: HY-P990901
CAS No.: 2796349-94-3
Synonyms: IGM-8444

Target:  

TNF Receptor Apoptosis

Research Areas:  

Cancer

Aplitabart (IGM-8444) is a pentameric IgM death receptor 5 (DR5) agonist antibody with a KD of 85 nM and an apparent affinity of 11 pM. Aplitabart induces DR5 multimerization, thereby triggering cancer cell apoptosis via the extrinsic apoptotic pathway apoptosis. Aplitabart is applicable to cancer-related research such as colorectal cancer and gastric cancer .
loading...
    loading...
Cat. No.: HY-P76849
Purity:  ≥ 95%, as determined by reducing SDS-PAGE.
Synonyms: Putative chondrosarcoma-associated gene 1 protein; CT24.1; Cancer/testis antigen CSAGE; CSAGE
Species:  
Source:  
loading...
    loading...
Cat. No.: HY-185905
CAS No.: 1811556-64-5
Target:  

Ser/Thr Protease

Research Areas:  

Inflammation/Immunology

TTAMRA-FP is an activity-based probe for serine hydrolases (Serine Hydrolase) that irreversibly and covalently labels the active-site serine of catalytically active serine hydrolases. TTAMRA-FP can be used for activity-based protein profiling of serine hydrolases and related studies on the activity of osteoarthritis-associated proteases .
loading...
    loading...